Welcome to our exciting symposium on precision cancer medicine in Helsinki! 

Registration is closed and all seats are filled.

The Symposium is streamed and the link is https://enchant.fi/icanfci/symposium2022 

For more information, please contact ican-fci@helsinki.fi

VENUE:  Hilton Helsinki Kalastajatorppa
Conference and Events Center, Kalastajatorpantie 1, Helsinki, tel: +358-945811

Thursday, September 22, 2022 - Siirtomaasali 1

8:00 –       Breakfast  & Registration

9:00          Opening words. Satu Mustjoki, iCAN Scientific Director, University of Helsinki & HUS Helsinki University Hospital

9:05          Awarding of the Eero Saksela prize by Vesa Kataja, Chair of the Scientific Advisory Board of the Finnish Cancer Institute

9:15          Special lecture: Kari Alitalo, University of Helsinki: A proxy of stemness and progression in intestinal cancer

10:00        Keynote: Peter Kraft, Harvard University: Polygenic risk scores and tailored cancer screening

10:45        Coffee, posters, and exhibition

SESSION 1. Chairs: Johanna Arola & Martti Färkkilä

11:15        Christian Meisel, Hedera Dx: Actionable ctDNA based insights for precision cancer medicine

11:45        Jesús Bañales, Biodonostia: Genetic background of primary sclerosing cholangitis associated cholangiocarcinoma (PSC-CCA)

12:15       Cyriel Ponsioen, Amsterdam AMC: Primary sclerosing cholangitis (PSC) dysplasia surveillance

12:45        Short presentation selected from abstracts: Nelli Sjöblom, HUS Helsinki University Hospital: Next generation sequencing of brush samples may improve detection of biliary neoplasia in PSC patients

13:00 – 14:00      Lunch, posters, and exhibition

SESSION 2. Chairs: Caroline Heckman & Markus Vähä-Koskela

14:00        Daniel Peeper, Netherlands Cancer Institute: Rational concepts for tumor & immune cell therapy combinations

14:30        Karin de Visser, Netherlands Cancer Institute: Innate-adaptive immune cell crosstalk dictates response to immune checkpoint blockade in breast cancer

15:00        René Medema, Netherlands Cancer Institute: Chromatin-dependent control of the DNA damage response 

15:30        Eero Saksela prize winner presentation

15:45       Group Photo, coffee

SESSION 3. Chairs: Tomi Mäkelä & Johanna Ivaska

16:15        Johanna Ivaska, University of Turku: Targeting KRAS-mutant cancers by disrupting KRAS-SHANK3 interaction

16:45        Francesca M. Buffa, University of Oxford: Machine Learning and Systems Biology approaches in Precision Oncology

17:15        Pekka Katajisto, University of Helsinki: Stem cells and tumorigenesis – a fight between self-renewing cells

17:45        Eero Saksela prize winner presentation

18:00        Adjournement

19:00-   Dinner at Kalastajatorppa, Pyöreä Sali

Friday, September 23, 2022 - Siirtomaasali 1

7:45          Breakfast & Registration

SESSION 4. Chairs: Tomi Mäkelä & Minna Anttonen

8:30          Special lecture: Bettina Ryll, Melanoma Patient Network Europe: From good to great: What patients can do for your research?

9:00          Panel discussion on patient involvement.

Moderators: Sara Lassfolk and Marketta Liljeström, iCAN Patient and Citizen Advisory Board.

Panel members: Sampsa Hautaniemi, University of Helsinki, Jarmo Wahlfors, Cancer Foundations Finland, Aino Kormilainen, HUS

9:30         Coffee, posters, and exhibition

SESSION 5. Chairs: Ilkka Ilonen & Tiina Vesterinen

10:00        Keynote: Pasi Jänne, Dana-Farber Cancer Institute, Harvard Medical School: Beyond the magic bullet

10:45        Prasad Adusumilli, Memorial Sloan Kettering Cancer Center: CAR-T cell therapy for solid tumors; new opportunities and challenges

11:15        Lynette Sholl, Brigham and Women’s Hospital/Harvard Medical School: Molecular diagnostics of cancer to support individualized therapy: perspectives from a clinical lab

11:45        Åslaug Helland, Oslo University Hospital: Personalized medicine in thoracic oncology; where are we now and where we are going – where we have the most to gain?

12:15 – 13:30  Lunch, posters, and exhibition

SESSION 6. Chairs: Sirpa Leppä & Päivi Ojala

13:30        Marco Gerlinger, Barts Cancer Institute and St Bartholomew’s Hospital, London: Gastrointestinal cancer evolution: mechanisms and implications for precision therapy

14:00        Kjetil Taskén, Institute of Cancer Research, Oslo University Hospital: A national precision cancer medicine implementation initiative for Norway

14:30        Short presentation selected from abstracts, Sakari Vanharanta, University of Helsinki: Lineage factor-dependent oncogenic signaling in kidney cancer

14:45       Coffee, posters, and exhibition

SESSION 7. Chairs: Päivi Ojala & Sirpa Leppä

15:15        Keynote: Michel Sadelain, Memorial Sloan Kettering Cancer Center: CAR T cells and the Living Drug Concept

16:00        Dario Campana, NUS Yong Loo Lin School of Medicine: Disrupting the treatment of lymphoid malignancies with CAR-T cells

16:30        Maria Themeli, Amsterdam UMC: Designing optimal dual-targeting of CAR T cells: the BETTER gate

17:00        Satu Mustjoki, University of Helsinki: Mechanisms of natural killer cell immune evasion by functional immune profiling

17:30        Closing words, Johanna Arola, the Chair of the Organizing Committee

17:45       Adjournement

 


Organising committee:

Johanna Arola,  chair

Tomi Mäkelä, vice chair

Caroline Heckman

Päivi Ojala

Sirpa Leppä

Ilkka Ilonen

Secretariat:

Tiina Vesterinen, FCI

Leena Karhinen, iCAN

Marketta Liljeström, iCAN PCAB

Satu Sankkila, iCAN

Saija Piiroinen, iCAN

Contact: ican-fci@helsinki.fi


Sponsors: